Table 2.
Descriptive statistics of baseline demographic and clinical scores in relation to adherence.
| % of adherence1 |
||||
|---|---|---|---|---|
| All (N = 101) | Did not start (n = 20) | 1 to 50% (N = 50) | ≥ 50% (N = 31) | |
| Demographic variables | ||||
| Age | 35.9 (11.9) | 32.4 (9.1) | 34.1 (11.5) | 40.3 (11.9) |
| Female sex | 58 (57.4%) | 10 (50.0%) | 27 (54.0%) | 19 (61.3%) |
| Higher education | 58 (57.4%) | 11 (55.0%) | 31 (62.0%) | 20 (64.5%) |
| Baseline diagnoses | ||||
| Dysthymia present | 8 (7.5%) | 3 (15.0%) | 5 (10.0%) | 0 (0%) |
| MDD present | 45 (44.6%) | 3 (15.0%) | 24 (48.0%) | 9 (29.0%) |
| SAD present | 52 (49.5%) | 5 (25.0%) | 30 (60.0%) | 15 (48.4%) |
| GAD present | 36 (34.3%) | 7 (35.0%) | 17 (34.0%) | 10 (32.3%) |
| Panic disorder present | 64 (61.0%) | 13 (65.0%) | 34 (68.0%) | 14 (45.2%) |
| Agoraphobia present | 19 (18.1%) | 5 (25.0%) | 8 (16.0%) | 6 (19.4%) |
| Specific phobia present | 61 (58.1%) | 12 (60.0%) | 28 (56.0%) | 18 (58.1%) |
| 2 or more specific phobias | 24 (22.9%) | 4 (20.0%) | 12 (24.0%) | 7 (22.6%) |
| 2 or more diagnoses | 82 (78.1%) | 16 (80.0%) | 41 (82.0%) | 21 (67.7%) |
| 3 or more diagnoses | 51 (48.6%) | 8 (40.0%) | 29 (58.0%) | 12 (38.7%) |
| Comorbid anxiety/depression | 46 (43.5%) | 10 (50.0%) | 25 (50.0%) | 9 (29.0%) |
| Using psychotropic medication | 14 (13.3%) | 0 (0%) | 5 (7.1%) | 8 (25.8%) |
| Baseline clinical scores | ||||
| FQ score (M/SD) | 42.0 (23.4) | 50.4 (21.9) | 45.8 (23.7) | 32.8 (21.7) |
| BAI score (M/SD) | 45.0 (13.8) | 50.8 (15.2) | 48.2 (13.4) | 36.9 (11.0) |
| CES-D score (M/SD) | 25.0 (8.6) | 27.7 (9.5) | 27.1 (8.7) | 20.2 (6.3) |
| EQ-5D score (M/SD) | 0.60 (0.28) | 0.51 (0.27) | 0.53 (0.28) | 0.74 (0.20) |
1
Adherence is defined as % of intended usage.